Abstract Submission Deadline: August 13, 2026
Abstract Submission Form will be open shortly
We invite researchers from academia, industry, and clinical practice to submit abstracts addressing innovative advances in RNA biology and RNA-based medicine. Topics of interest include, but are not limited to:
- RNA Processing & Mis-splicing in Human Disease
- Splicing factor mutations, disease mechanisms, and therapeutic correction
- Splicing factor mutations, disease mechanisms, and therapeutic correction
- Epitranscriptomic Regulation in Cancer, Immunity & Aging
- m⁶A, A-to-I editing, and other RNA modifications as biomarkers and therapeutic targets.
- m⁶A, A-to-I editing, and other RNA modifications as biomarkers and therapeutic targets.
- RNA-Based Immune Modulation
- Reprogramming T cells, NK cells, and myeloid cells using RNA technologies.
- Reprogramming T cells, NK cells, and myeloid cells using RNA technologies.
- mRNA Vaccines & Personalized RNA Immunotherapy
- Personalized neoantigen vaccines, self-amplifying mRNA, and combinational immunotherapy.
- Personalized neoantigen vaccines, self-amplifying mRNA, and combinational immunotherapy.
- RNA Therapeutics for Genetic & Rare Disorders
- ASOs, siRNA, and RNA editing for monogenic and complex diseases.
- ASOs, siRNA, and RNA editing for monogenic and complex diseases.
- RNA Biomarkers & Precision Medicine
- Cell-free RNA, exosomal RNA, splicing signatures, and predictive diagnostics
- Cell-free RNA, exosomal RNA, splicing signatures, and predictive diagnostics
- RNA-Mediated Tumor Microenvironment Modulation
- Strategies to enhance immunogenicity and overcome resistance to immunotherapy.
- Strategies to enhance immunogenicity and overcome resistance to immunotherapy.
- RNA Delivery Technologies
- LNP advancements, cell-specific delivery systems, and organ-targeted vectors
- LNP advancements, cell-specific delivery systems, and organ-targeted vectors
- Non-coding RNAs as Drug Targets
- Functional characterization and therapeutic targeting of lncRNAs, circRNAs, and microRNAs.
- Functional characterization and therapeutic targeting of lncRNAs, circRNAs, and microRNAs.
- AI in RNA Medicine
- Computational prediction of splicing, RNA structure, and therapeutic design.
SUBMISSION CATEGORIES
- Oral presentations
- Rapid-fire talks
- Posters
- Translational / clinical updates
- Industry innovations
GUIDELINES FOR ABSTRACT SUBMISSION
- Abstracts should be submitted via the on-line submission system only.
- All abstracts must be submitted and presented in English.
- All abstracts submitted online will be reviewed by the Scientific Committee and notification of acceptance will be sent by email.
- To correct/change an abstract that has already been submitted or to submit another abstract, please use the log-in and password which you received when you submitted your original abstract. This will enable you to access the previously submitted abstract/s or to submit an additional abstract/s.
- The abstract text should be up to 300-word limit (with title, author names and affiliation details excluded) and cannot include tables and graphs.
- Abstracts should have the conventional layout: Background, Method, Results and Conclusion.
- Modification of abstracts will not be possible later than the above deadline.
If you have any questions, please contact Ms. Phillipa Friedland: pfriedland@kenes-exhibitions.com
